Patents by Inventor Jeffrey D. Wuitschick

Jeffrey D. Wuitschick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AMPLIFICATION OF NUCLEIC ACIDS
    Publication number: 20220169622
    Abstract: Provided herein is technology relating to amplification of nucleic acids and particularly, but not exclusively, to compositions and methods for doing improving the polymerase chain reaction and providing reagents for polymerase chain reaction with improved stability.
    Type: Application
    Filed: February 15, 2022
    Publication date: June 2, 2022
    Inventors: Tomasz Krupinski, Jeffrey D. Wuitschick, Shihai Huang
  • EGFR assay
    Patent number: 11279982
    Abstract: Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.
    Type: Grant
    Filed: January 2, 2020
    Date of Patent: March 22, 2022
    Assignee: ABBOTT MOLECULAR INC.
    Inventors: Jeffrey D. Wuitschick, Kevin S. Nelson, Shihai Huang, Rupinder Kular, Carolyn Mullen, James Rhoads
  • Amplification of nucleic acids
    Patent number: 11274086
    Abstract: Provided herein is technology relating to amplification of nucleic acids and particularly, but not exclusively, to compositions and methods for doing improving the polymerase chain reaction and providing reagents for polymerase chain reaction with improved stability.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: March 15, 2022
    Assignee: Abbott Molecular Inc.
    Inventors: Tomasz Krupinski, Jeffrey D. Wuitschick, Shihai Huang
  • AMPLIFICATION OF NUCLEIC ACIDS
    Publication number: 20200207729
    Abstract: Provided herein is technology relating to amplification of nucleic acids and particularly, but not exclusively, to compositions and methods for doing improving the polymerase chain reaction and providing reagents for polymerase chain reaction with improved stability.
    Type: Application
    Filed: December 20, 2019
    Publication date: July 2, 2020
    Inventors: Tomasz Krupinski, Jeffrey D. Wuitschick, Shihai Huang
  • EGFR ASSAY
    Publication number: 20200172983
    Abstract: Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.
    Type: Application
    Filed: January 2, 2020
    Publication date: June 4, 2020
    Inventors: Jeffrey D. Wuitschick, Kevin S. Nelson, Shihai Huang, Rupinder Kular, Carolyn Mullen, James Rhoads
  • EGFR assay
    Patent number: 10538815
    Abstract: Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.
    Type: Grant
    Filed: June 23, 2016
    Date of Patent: January 21, 2020
    Assignee: ABBOTT MOLECULAR INC.
    Inventors: Jeffrey D. Wuitschick, Kevin S. Nelson, Shihai Huang, Rupinder Kular, Carolyn Mullen, James Rhoads
  • EGFR ASSAY
    Publication number: 20160376665
    Abstract: Provided herein is technology relating to detecting molecular markers relevant to cancer and particularly, but not exclusively, to methods and compositions for quantifying and/or detecting EGFR mRNA and/or EGFRvIII mRNA in biological samples.
    Type: Application
    Filed: June 23, 2016
    Publication date: December 29, 2016
    Inventors: Jeffrey D. Wuitschick, Kevin S. Nelson, Shihai Huang, Rupinder Kular, Carolyn Mullen, James Rhoads
  • METHOD FOR AMPLIFICATION AND ASSAY OF RNA FUSION GENE VARIANTS, METHOD OF DISTINGUISHING SAME AND RELATED PRIMERS, PROBES, AND KITS
    Publication number: 20140272956
    Abstract: Method for amplification, alone or in further combination with detection or detection and quantitation, of RNA from fusion gene variants, method of distinguishing same, and oligonucleotide primers and probes and kits for use in the methods.
    Type: Application
    Filed: March 11, 2014
    Publication date: September 18, 2014
    Applicant: ABBOTT MOLECULAR INC.
    Inventors: Shihai X. Huang, Jeffrey D. Wuitschick
  • PRAME DETECTION ASSAYS
    Publication number: 20140072971
    Abstract: Provided herein are molecular assays, including oligonucleotides and other reagents, for the detection and analysis of PRAME (Preferentially Expressed Antigen in Melanoma). The assays find use, for example, as diagnostic and prognostic applications, including use in assessing therapeutic courses of action.
    Type: Application
    Filed: August 30, 2013
    Publication date: March 13, 2014
    Applicant: ABBOTT LABORATORIES
    Inventors: Jeffrey D. Wuitschick, Shihai Huang